# US 6,727,233 B1 · Medicinal compositions for treating osseous lesion in multiple myeloma

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,727,233 B1
- Document ID: US6727233B1
- Status: Granted
- Kind: B1
- Application number: 09/869,122
- Filed: 2001-06-25
- Granted: 2004-04-27
- Earliest claimed: 1998-12-25
- Assignees: Yamanouchi Pharmaceutical Co., Ltd.
- Inventors: Shohei Tanaka; Utane Matsukawa; Hironobu Asano
- Web page: https://patentgrep.com/patent/US6727233B1

## CPC

- A61K 31/675: having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A61P 19/08: for bone diseases, e.g. rachitism, Paget's disease
- A61P 35/00: Antineoplastic agents
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Pharmaceutical compositions for treating bone lesions in multiple myeloma or pharmaceutical compositions for treating multiple myeloma which contain as an active ingredient a compound having both of an effect of suppressing bone resorption accompanying multiple myeloma and an effect of inhibiting multiple myeloma, more particularly, 1-hydroxy-2-(imidazo[1,2-a]pyridin-3-yl)ethane-1,1-bisphosphonic acid or its salt.

## Claims

### Claim 1

A method for treating multiple myeloma by both inhibiting proliferation of myeloma cells and suppressing bone resorption comprising, administering to a patient suffering from multiple myeloma and bone lesions 1 to 20 mg per day of 1-hydroxy-2-(imidazo[1,2-a]pyridin-3-yl)ethane-1,1-bisphosphonic acid, or a salt thereof, and a pharmaceutically acceptable carrier or diluent.

### Claim 2

A method for treating multiple myeloma by both inhibiting proliferation of myeloma cells and suppressing bone resorption comprising, administering to a patient suffering from multiple myeloma and bone lesions 3 to 10 mg per day of 1-hydroxy-2-(imidazo[1,2-a]pyridin-3-yl)ethane-1,1-bisphosphonic acid, or a salt thereof, and a pharmaceutically acceptable carrier or diluent.

### Claim 3

A method for treating multiple myeloma by both inhibiting proliferation of myeloma cells and suppressing bone resorption comprising, orally administering to a patient suffering from multiple myeloma and bone lesions a pharmaceutically effective amount of 1-hydroxy-2-(imidazo[1,2-a]pyridin-3-yl)ethane-1,1-bisphosphonic acid, or a salt thereof, and a pharmaceutically acceptable carrier or diluent.
